You are here:Home-Chemical Inhibitors & Agonists-PI3K/Akt/mTOR Pathway-PI3K-Tenalisib
Tenalisib

Chemical Structure : Tenalisib

CAS No.: 1639417-53-0

Tenalisib (RP-6530;RP 6530;RP6530)

Catalog No.: PC-60567Not For Human Use, Lab Use Only.

Tenalisib (RP-6530) is a potent, selective, orally active p110δ/γ PI3K dual inhibitor with IC50 of 24.5 and 33.2 nM, respectively.

Packing Price Stock Quantity
10 mg $128 In stock
25 mg $218 In stock
50 mg $378 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Tenalisib (RP-6530) is a potent, selective, orally active p110δ/γ PI3K dual inhibitor with IC50 of 24.5 and 33.2 nM, respectively.
Tenalisib (RP-6530) displays good selectivity over p110α (>300-fold) and p110β (>100-fold) isoforms.
Tenalisib (RP-6530) inhibits LPS induced CD19+ cell proliferation in human whole blood with EC50 of 250 nM, and LPS induced CD45R+ cell proliferation in mouse whole blood with EC50 of 101 nM.
Tenalisib (RP-6530) shows the potential for treatment of cancer and inflammation diseases.

Physicochemical Properties

M.Wt 415.43
Formula C23H18FN5O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(S)-2-(1-((7H-purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one

References

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: